Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
ID: 356212Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356212

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-258.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the Cooperative Agreement mechanism to support a Human Tissue and Organ Research Resource program. This initiative aims to enhance the availability of human tissues and organs for biomedical research, facilitating their procurement, preservation, and distribution to qualified researchers, thereby contributing to the understanding of various diseases and conditions. The program is particularly focused on reducing morbidity and mortality related to disease through robust human tissue research, with a funding cap of $720,000 available over a maximum period of five years. Interested applicants, including higher education institutions and nonprofits, are encouraged to apply starting December 24, 2024, with the first round of funding anticipated to begin on January 24, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-258-Full-Announcement.html
    PAR-24-258.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and its Office of Research Infrastructure Programs (ORIP), has announced a funding opportunity (PAR-24-258) to support a Human Tissue and Organ Research Resource program. This initiative aims to facilitate the procurement, preservation, and distribution of human tissues and organs for biomedical research, enhancing scientists' ability to study various diseases and conditions. The funding mechanism is a cooperative agreement, disallowing clinical trials, with a funding cap of $720,000 over a maximum period of five years. Eligible applicants include higher education institutions, nonprofits, and various government entities, with particular encouragement for those serving underrepresented populations. Applications will undergo a rigorous peer review, assessing significance, investigator qualifications, innovation, approach, and the institutional environment. The overarching goal is to reduce morbidity and mortality related to disease through robust human tissue research, fostering increased collaboration between research institutions and NIH. Key dates include application submission openings on December 24, 2024, and the first round of anticipated funding starting January 24, 2025. Successful applicants must demonstrate prior experience in managing human tissue resources and adherence to strict operational and ethical guidelines.
    Similar Opportunities
    Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening (Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening," aimed at developing and validating advanced 3-D tissue models for drug efficacy testing. This initiative seeks to create non-animal models that accurately mimic the physiological properties of human tissues, thereby enhancing the predictive accuracy of drug screening processes. With an estimated total program funding of $1,600,000 and the expectation of awarding two grants, interested applicants are encouraged to utilize the resources available at the NCATS 3-D Bioprinting laboratory. The application process is open to various eligible entities, excluding non-domestic applicants, with a submission deadline anticipated by June 16, 2026. For further inquiries, potential applicants can contact Dobrila D. Rudnicki, Ph.D., at dobrila.rudnicki@nih.gov or by phone at 240-535-6621.
    Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the establishment of Animal and Biological Material Resource Centers under the Notice of Funding Opportunity (NOFO) RFA-OD-25-011. This initiative aims to support the creation, preservation, and distribution of high-quality laboratory animals and biological materials, while also integrating new approach methodologies (NAMs) that complement traditional animal-based research. The program is crucial for enhancing research infrastructure and ensuring the availability of resources that facilitate scientific rigor and reproducibility in biomedical research. A total funding amount of $1.3 million is anticipated to support at least two awards annually from FY 2023-2025, with applications due by January 9, 2029. Interested applicants can reach out to the Office of Research Infrastructure Programs at ORIPDCM@mail.nih.gov for further information.
    Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a non-competitive funding opportunity for a cooperative agreement to support the Human Genetic Cell Repository (HGCR), with a focus on maintaining and distributing a diverse collection of human cell lines and DNA samples for biomedical research. The initiative aims to enhance the repository's capacity by acquiring new cell lines from diverse populations, ensuring ethical practices in sample collection, and promoting inclusivity in research efforts. This funding opportunity provides up to $1.75 million annually for a five-year project period, with applications due by June 10, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the funding announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-055.html.
    Forecast for The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the NINDS Human Biospecimen and Data Repository, aimed at advancing research in neurological disorders. This initiative will establish a repository to maintain and expand a collection of biospecimens, which will be made available to qualified academic and industry researchers to support basic, translational, and clinical research efforts. The total estimated funding for this program is $1,950,000, with one award anticipated, and interested applicants are encouraged to begin forming collaborations and developing proposals ahead of the expected synopsis posting on August 25, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Price at rebecca.price@nih.gov or by phone at 301-827-3587.
    Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)," aimed at improving the utility of mammalian cancer models in translational research. This initiative seeks projects that enhance the accuracy and application of models, such as organoids and tumoroids, to better represent human biology and inform clinical practices, addressing current limitations and fostering innovation in cancer research methodologies. Eligible applicants include a diverse range of organizations, such as higher education institutions and community-based organizations, with a maximum funding amount of $499,000 per year for projects not exceeding five years. Interested parties should submit their applications through Grants.gov, with deadlines beginning January 5, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)." This funding aims to support small businesses in developing, characterizing, or improving research models related to human health and diseases, as well as creating new approach methodologies (NAMs) that enhance the accessibility and translational value of experimental research models. The initiative is crucial for advancing biomedical research and ensuring that developed resources are broadly applicable across multiple NIH Institutes or Centers. The estimated total program funding is $5 million, with approximately six awards expected. Interested applicants should prepare to submit their proposals by January 25, 2026, with the anticipated award date set for October 1, 2026. For further inquiries, contact Sige Zou, PhD, at 301-435-0749 or via email at sige.zou@nih.gov.
    Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Kidney Precision Medicine Project (KPMP) - Tissue Interrogation Sites (TIS) through a cooperative agreement, aimed at analyzing human kidney tissue. The primary objective is to collaborate with various sites to obtain and evaluate kidney biopsies from participants suffering from acute kidney injury (AKI) or chronic kidney disease (CKD), ultimately creating a Kidney Tissue Atlas and identifying critical disease subgroups and therapeutic targets. This initiative is crucial for advancing kidney disease research and developing novel therapies, with an estimated total program funding of $6 million and an expected seven awards to be made. Interested applicants can reach out to Debbie S. Gipson at Debbie.Gipson@nih.gov or by phone at 301-480-2268, with applications due by October 5, 2026, and project start anticipated on July 1, 2027.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated, high-risk multi-center clinical trials through the Notice of Funding Opportunity (NOFO) PA-25-147. This cooperative agreement (U01) aims to support innovative studies that address critical health issues related to diabetes, digestive diseases, and kidney conditions, requiring proposals to be hypothesis-driven and operationally classified as high-risk. The program emphasizes the importance of diverse perspectives in research and mandates that planning activities be completed prior to application submission. Interested applicants should note that the application period opens on January 3, 2025, with a submission deadline of November 5, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)" aimed at supporting the development, production, and distribution of nonhuman primate-specific immunologic reagents. This initiative, led by the National Institute of Allergy and Infectious Diseases (NIAID), seeks to enhance preclinical research in nonhuman primate models to accelerate advancements in cures, vaccines, and treatments for immune-mediated diseases and emerging infectious diseases. The estimated total program funding is $1,300,000, with one award expected, and applications are anticipated to be solicited starting in late August 2025, with a closing date in late October 2025. Interested applicants can reach out to Dr. Shilpa Kulkarni at shilpa.kulkarni@nih.gov or call 240-747-7365 for further information.
    Resource-based Centers for Bone, Muscle and Orthopaedic Research
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to announce a funding opportunity for Resource-based Centers focused on Bone, Muscle, and Orthopaedic Research. This initiative aims to establish centers that will provide essential research infrastructure, shared facilities, and resources to support investigators in conducting efficient and effective research projects in these critical areas. The goal is to enhance ongoing basic, translational, and clinical research aligned with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). While applications are not currently being solicited, potential applicants are encouraged to develop collaborations and project proposals in anticipation of the funding announcement, which is expected to be published in September 2025. Interested parties can reach out to Dr. Mary Garcia-Cazarin at mary.garcia-cazarin@nih.gov or by phone at 301-451-2937 for further information.